ArticleFrontiers in immunology2026

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Jianing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.